VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on ...

Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit

Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced that it will present at the upcoming ...

Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and Assembly

Approximately $28 million in planned TRUKING equipment advances domestic manufacturing capacity, strengthens the Company’s preparedness strategy, ...
BIOENGINEER

Pharmaceutical Scientists Rally Around Particle Engineering for Next-Generation Drug Forms

The Journal of Pharmaceutical Investigation has announced a January 2027 special issue, led by three Korean guest editors, ...
PRWeb

Atomica Launches Biotechnology Microdevices Platform to Accelerate Breakthroughs in Diagnostics and Drug Delivery

Atomica, a U.S.-based microfabrication foundry, today announced the launch of its Biotechnology Microdevices Platform, the seventh in ...
STAT

Biotech’s bold new mandate: Breakthroughs beyond the lab

Charlotte Owens, M.D., spends a lot of time flying across the country to lead in two very different roles. In South San Francisco, she leads medical affairs at Genentech, which emerged as the world’s ...
Inc.

The Hidden Reason Biotech Breakthroughs Keep Getting Delayed

Biotech is full of brilliant people solving problems most people can barely describe, let alone understand. However, after spending time at BIO2026 and interviewing leaders across the industry, one ...

VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress

Austin, Texas, September 24th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its ...
Wall Street Journal

Biotech Insider Sounds the Alarm on His Industry

The U.S. biotechnology industry is healthier than it has been in years—stock prices and mergers and acquisitions are surging and companies are making breakthroughs in diseases, such as pancreatic ...

VERAXA Biotech (VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its ...